Tower Research Capital LLC TRC Boosts Position in ProShares Ultra Nasdaq Biotechnology (BIB)

Tower Research Capital LLC TRC increased its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 153.3% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,093 shares of the exchange traded fund’s stock after purchasing an additional 16,397 shares during the period. Tower Research Capital LLC TRC owned 0.44% of ProShares Ultra Nasdaq Biotechnology worth $1,887,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. HRT Financial LLC bought a new position in ProShares Ultra Nasdaq Biotechnology in the second quarter worth about $258,000. Private Capital Advisors Inc. bought a new position in ProShares Ultra Nasdaq Biotechnology in the third quarter worth about $612,000. Finally, Howard Capital Management Inc. bought a new position in ProShares Ultra Nasdaq Biotechnology in the third quarter worth about $6,933,000.

Shares of NASDAQ BIB opened at $54.44 on Friday. ProShares Ultra Nasdaq Biotechnology has a 52-week low of $46.69 and a 52-week high of $70.82.

ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.com-unik.info/2018/12/02/tower-research-capital-llc-trc-boosts-position-in-proshares-ultra-nasdaq-biotechnology-bib.html.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Read More: Understanding Average Daily Trade Volume

Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB).

Institutional Ownership by Quarter for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit